San Francisco, California, February 09, 2018: A recent market research report by TMR Research is a detailed compilation of insightful facts, data, statistical information, and comprehensive analysis of the global market for active implantable medical devices. The report is titled “Active Implantable Medical Devices Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017–2025.”
The report states that the market will witness a substantial rise in its valuation and geographical outreach over the period between 2017 and 2025. The market is expected to benefit massively from the rising prevalence of a number of cardiovascular and neurological conditions and encouraging medical reimbursement policies across a number of countries. The rapid pace of technological advancement and easy availability of a variety of advanced and highly effective products are also likely to work in favor of the global active implantable medical devices market over the estimated period.
Companies operating in the global active implantable medical device market are investing large sums in research and development activities aimed at the development of economical products to exploit the vast set of growth opportunities in cost-sensitive emerging economies. This trend is expected to massively help the global active implantable medical device market expand at a healthy pace. However, the dearth of professions skilled in performing implant surgeries, not only across developing but also certain developed regions, could emerge as one of the key challenges ahead of the global active implantable medical devices market.
Geographically, the report covers the market for regions such as North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. It is estimated that the market in North America is presently the most promising regional market and is likely to remain the dominant regional market in terms of revenue generation opportunities in the global market over the report’s forecast period. The strong growth prospects of the market in North America can be attributed to the conducive environment for research and development activities, the presence of several leading medical device companies, well-developed healthcare infrastructure, and high awareness about advanced medical devices among the population. The rising prevalence of neurological and cardiovascular diseases and rising expenditure on healthcare are also estimated to work in favor of the North America active implantable medical devices market.
In the next few years, the Asia Pacific market for active implantable medical devices is expected to emerge as one of the most lucrative regional markets owing to the rise of vast growth opportunities in the form of rising population of geriatrics, increased expenditure on healthcare, and the rising prevalence of cardiovascular disease. Moreover, an increased focus of governments on the improvement of healthcare infrastructure is also expected to aid the expansion of the market.
The market study on the global active implantable medical devices market outlines product offerings, recent developments, key company facts, SWOT analysis, and business strategies. Presenting a detailed account of the vendor landscape of the market keeping in mind the aforementioned categories, the market research study examines the contribution of numerous companies operating in the global active implantable medical devices market. Some of the leading companies in the market are Medtronic PLC, Abbott Laboratories, Biotronik Se & Co., Kg, Nurotron Biotechnology Co. Ltd., William Demant Holding A/S, Boston Scientific Corporation, Livanova PLC, Med-EL, Cochlear Limited, and Sonova Holding AG.
Get Sample Copy of this Report